Recent Advances on Drugs and Vaccines for COVID-19

The current situation of Coronavirus Disease 2019 (COVID-19) worldwide is still very severe. Presently, many breakthroughs have been accomplished in the research and development of drugs for the treatment of COVID-19, especially vaccines; however, some of the so-called COVID-19-specific drugs highli...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fang Peng MD, Hao Yuan PhD, Sixian Wu MD, Yifeng Zhou MD
Formato:	article
Lenguaje:	EN
Publicado:	SAGE Publishing 2021
Materias:	Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/49ff8f58b33144d2a0eea9032c04b4aa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:49ff8f58b33144d2a0eea9032c04b4aa
record_format	dspace
spelling	oai:doaj.org-article:49ff8f58b33144d2a0eea9032c04b4aa2021-12-01T22:34:41ZRecent Advances on Drugs and Vaccines for COVID-190046-95801945-724310.1177/00469580211055630https://doaj.org/article/49ff8f58b33144d2a0eea9032c04b4aa2021-11-01T00:00:00Zhttps://doi.org/10.1177/00469580211055630https://doaj.org/toc/0046-9580https://doaj.org/toc/1945-7243The current situation of Coronavirus Disease 2019 (COVID-19) worldwide is still very severe. Presently, many breakthroughs have been accomplished in the research and development of drugs for the treatment of COVID-19, especially vaccines; however, some of the so-called COVID-19-specific drugs highlighted in the early stage failed to achieve the expected curative effect. There is no antiviral therapy available, by stimulating protective immunity vaccine is the best choice for the future management of infection. Therefore, we aimed to identify the latest developments in the research and development of these drugs and vaccines and provide a reference for the prevention and treatment of COVID-19.Fang Peng MDHao Yuan PhDSixian Wu MDYifeng Zhou MDSAGE PublishingarticlePublic aspects of medicineRA1-1270ENInquiry: The Journal of Health Care Organization, Provision, and Financing, Vol 58 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Public aspects of medicine RA1-1270
spellingShingle	Public aspects of medicine RA1-1270 Fang Peng MD Hao Yuan PhD Sixian Wu MD Yifeng Zhou MD Recent Advances on Drugs and Vaccines for COVID-19
description	The current situation of Coronavirus Disease 2019 (COVID-19) worldwide is still very severe. Presently, many breakthroughs have been accomplished in the research and development of drugs for the treatment of COVID-19, especially vaccines; however, some of the so-called COVID-19-specific drugs highlighted in the early stage failed to achieve the expected curative effect. There is no antiviral therapy available, by stimulating protective immunity vaccine is the best choice for the future management of infection. Therefore, we aimed to identify the latest developments in the research and development of these drugs and vaccines and provide a reference for the prevention and treatment of COVID-19.
format	article
author	Fang Peng MD Hao Yuan PhD Sixian Wu MD Yifeng Zhou MD
author_facet	Fang Peng MD Hao Yuan PhD Sixian Wu MD Yifeng Zhou MD
author_sort	Fang Peng MD
title	Recent Advances on Drugs and Vaccines for COVID-19
title_short	Recent Advances on Drugs and Vaccines for COVID-19
title_full	Recent Advances on Drugs and Vaccines for COVID-19
title_fullStr	Recent Advances on Drugs and Vaccines for COVID-19
title_full_unstemmed	Recent Advances on Drugs and Vaccines for COVID-19
title_sort	recent advances on drugs and vaccines for covid-19
publisher	SAGE Publishing
publishDate	2021
url	https://doaj.org/article/49ff8f58b33144d2a0eea9032c04b4aa
work_keys_str_mv	AT fangpengmd recentadvancesondrugsandvaccinesforcovid19 AT haoyuanphd recentadvancesondrugsandvaccinesforcovid19 AT sixianwumd recentadvancesondrugsandvaccinesforcovid19 AT yifengzhoumd recentadvancesondrugsandvaccinesforcovid19
_version_	1718404097900544000

Recent Advances on Drugs and Vaccines for COVID-19

Ejemplares similares